We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Phosphate Sandoz phosphorus 500mg effervescent tablets
Section 19A approved medicine
(Approval lapsed) Phosphate Sandoz phosphorus 500mg effervescent tablets
Section 19A approval holder
Phebra Pty Ltd ABN 77 695 661 635
Phone
02 9420 9199
Approved until
Status
Expired
Medicines in short supply/unavailable
Phosphate - Sandoz Tablets - ARTG 13368
Indication(s)
- Hypercalcaemia associated with such conditions as hyperparathyroidism, multiple myelomatosis and malignancy.
- Hypophosphataemia associated with vitamin D resistant rickets.
Additional information